Kahma Biotech

About Kahma Biotech
The founders of the Kahma Healthcare Group established The Biovac Institute – the only local human vaccines manufacturing entity in partnership with the South African government.
Since its inception Biovac has grown from strength-to-strength and today is an independent company controlled and owned by Kahma’s empowerment partners.
Kahma Biotech enjoys a strategic and synergistic relationship with Biovac, where Kahma focuses mainly on the commercialisation of biotech products including vaccines targeted at adults whilst Biovac is a specialist vaccine manufacturing company.
Professional Information Leaflets
Casfin
50mg and 70mg
500mg
Micononin
50mg and 100mg
Nivazen
1mg
Chirorab
1ml
0.1ml
75µg
30mg
Urilosin
0.4mg
Clozurb
10mg and 2mg
Drug Safety
For safety issues/adverse event or a complaint around a product, please report it to us using pv@kahmagroup.co.za